Michael Petusky

Stock Analyst at Barrington Research

(2.07)
# 2,908
Out of 4,868 analysts
196
Total ratings
36.42%
Success rate
-6.53%
Average return

Stocks Rated by Michael Petusky

ModivCare
May 12, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $3.62
Upside: -
DENTSPLY SIRONA
May 12, 2025
Maintains: Outperform
Price Target: $20$21
Current: $15.40
Upside: +36.36%
Anika Therapeutics
May 12, 2025
Maintains: Outperform
Price Target: $20$19
Current: $11.10
Upside: +71.17%
Henry Schein
May 6, 2025
Maintains: Outperform
Price Target: $90$86
Current: $71.13
Upside: +20.91%
OPKO Health
May 1, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.29
Upside: +74.42%
Option Care Health
Apr 30, 2025
Maintains: Outperform
Price Target: $38
Current: $31.56
Upside: +20.41%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$103
Current: $92.95
Upside: +10.81%
VerifyMe
Mar 7, 2025
Maintains: Outperform
Price Target: $1.5$1.25
Current: $0.76
Upside: +64.89%
U.S. Physical Therapy
Feb 28, 2025
Maintains: Outperform
Price Target: $108$98
Current: $73.79
Upside: +32.81%
LeMaitre Vascular
Feb 28, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $81.76
Upside: -
Maintains: Outperform
Price Target: $108$95
Current: $70.06
Upside: +35.60%
Downgrades: Market Perform
Price Target: n/a
Current: $6.71
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $29.14
Upside: -